Results 261 to 270 of about 307,775 (306)
Some of the next articles are maybe not open access.
Preclinical Evaluation of Cudetaxestat for Potential Drug-Drug Interactions
B36. SPECTRUM OF FIBROTIC INTERSTITIAL LUNG DISEASES, 2022W. Yu +3 more
openaire +1 more source
ChemInform Abstract: Drug Safety Evaluation at the Preclinical Stage
ChemInform, 1991AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
openaire +1 more source
Treatment of schizophrenia: A clinical and preclinical evaluation of neuroleptic drugs
Pharmacology & Therapeutics, 1993Forty years after the first clinical report on the effectiveness of chlorpromazine in psychiatric patients, neuroleptic drugs are still the most widely used drugs in the treatment of schizophrenia. Indeed, there are no other drugs which have proven to be as effective in the treatment of this severe psychiatric disorder.
openaire +2 more sources
Preclinical evaluation of drug effects on testicular functions
Pharmacology & Therapeutics, 1979F, Neumann, B, Schenck
openaire +2 more sources
Preclinical Evaluation of Neuraxial Drugs for Safety
2023Tony L. Yaksh +2 more
openaire +1 more source
Evaluation of Antiseptic Drug Candidate Pyridosept in Preclinical in Vitro Studies
Current Medicinal ChemistryIntroduction: This work provides preclinical in vitro studies of an innovative antimicrobial agent named pyridosept, belonging to the quaternary bis-ammonium salts and synthesized on the base of pyridoxine. Since the wide spread of pathogens with tolerance to both antibiotics and antiseptics challenges the ...
Renata Kazakova +20 more
openaire +2 more sources
Human malignant melanoma: preclinical and clinical drug evaluation.
Behring Institute Mitteilungen, 1984A panel of 17 melanoma xenograft lines was exposed to various DNA reactive agents. Growth delay values were calculated from tumor volume responses of xenograft bearing mice and correlated with donor patient's response as determined by standard clinical criteria.
openaire +1 more source
Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials
Nature Reviews Drug Discovery, 2021E Elizabeth Patton +2 more
exaly
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly